Physician profile
Mina E Ohm
NPI 1609955954
$3,344.45
in general payments reported to CMS, 2019-2025
6 companies · $685 in 2025
The $685 reported for 2025 was more than what 75% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $83.33 · 2021: $230 · 2022: $491 · 2023: $1,217 · 2024: $532 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,660.36 | 2019-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Johnson & Johnson Health Care Systems INC. | $520.48 | 2023-2025 | Invega Sustenna, Spravato, Tecvayli |
| Teva Pharmaceuticals USA, INC. | $444.77 | 2020-2023 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $385.42 | 2022-2024 | Rexulti, Abilify Maintena |
| Eisai INC. | $219.13 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $114.29 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Ohm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.